Effect of high-flow nasal therapy during exercise training in COPD patients with chronic respiratory failure: study protocol for a randomised controlled trial

被引:7
|
作者
Vitacca, Michele [1 ]
Pietta, Irene [2 ]
Lazzeri, Marta [3 ]
Paneroni, Mara [1 ]
机构
[1] Ist Clin Sci Maugeri IRCCS, Resp Rehabil Inst Lumezzane, Brescia, Italy
[2] ARIR Assoc, Milan, Italy
[3] Osped Niguarda Ca Granda, Milan, Italy
关键词
Rehabilitation; Exercise tolerance; Oxygen; Outcome; OBSTRUCTIVE PULMONARY-DISEASE; FIELD WALKING TESTS; GAS-EXCHANGE; REHABILITATION; EFFICACY; OXYGEN; INTENSITY; TOLERANCE; HYPEROXIA; DYSPNEA;
D O I
10.1186/s13063-019-3440-2
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BackgroundThe benefit of pulmonary rehabilitation (PR) in symptomatic chronic obstructive pulmonary disease (COPD) is well known. However, advanced patients with chronic respiratory failure (CRF), a category excluded from most studies, are frequently unable to sustain a work-load sufficiently high to obtain the full benefit of PR on exercise tolerance. Recent studies involving heated and humidified high flow oxygen therapy (HFOT) showed positive effects on breathing pattern and ventilatory efficiency during effort. We thus plan to compare, in COPD patients with CRF undergoing a high-intensity exercise programme, the effect of using HFOT versus standard oxygen delivery via Venturi Mask (V-mask), at the same inspiratory oxygen fraction, on improving exercise endurance.Methods/DesignThis is a multicentre randomised controlled trial that will involve 156 COPD inpatients with CRF recruited from seven PR hospitals. Patients will be randomised to one of two groups - V-mask versus HFOT. All patients will undergo the same high-intensity exercise programme using either of the oxygen delivery devices as per their group allocation. Training will consist of 20 sessions, over 1month (5 sessions per week) within the hospitalisation period. Anthropometric and clinical data, including body mass index, diagnosis, spirometry and comorbidities (Cumulative Rating Scale) will be collected at baseline. At baseline and at the end of the exercise programme (primary assessment time) evaluation will include exercise tolerance (Constant Work Rate Exercise Test) (primary outcome), functional capacity (6-min walk test), maximal inspiratory pressure/maximal expiratory pressure, peripheral muscle strength (biceps and quadriceps) by manual dynamometer, respiratory exchanges (blood gases analysis), disability (Barthel Index and Barthel Dyspnoea Index), impact of disease (COPD Assessment test), and quality of life (Maugeri Respiratory Failure Scale-26). At the end of the training period, patient satisfaction will be evaluated.DiscussionThis study will add knowledge about the exercise response in advanced COPD with CRF and verify if an alternative tool, namely HFOT, can increase the benefit obtained from PR.Trial registrationClinicalTrials.gov ID NET03322787Registered: 6 November 2017
引用
收藏
页数:8
相关论文
共 50 条
  • [41] In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy
    Bennett, Gavin
    Joyce, Mary
    Sweeney, Louise
    MacLoughlin, Ronan
    PULMONARY THERAPY, 2019, 5 (01) : 43 - 54
  • [42] Laryngeal mask airway or high-flow nasal cannula versus nasal cannula for advanced bronchoscopy: a randomised controlled trial
    Gavriely, Regina Pikman
    Freund, Ophir
    Tiran, Boaz
    Perluk, Tal Moshe
    Kleinhendler, Eyal
    Matot, Idit
    Bar-Shai, Amir
    Gershman, Evgeni
    ERJ OPEN RESEARCH, 2025, 11 (01)
  • [43] Study protocol: a randomised controlled trial investigating the effect of exercise training on peripheral blood gene expression in patients with stable angina
    Bourke, Liam
    Tew, Garry A.
    Milo, Marta
    Crossman, David C.
    Saxton, John M.
    Chico, Timothy J. A.
    BMC PUBLIC HEALTH, 2010, 10
  • [44] High-flow nasal cannula in adults with chronic respiratory diseases during physical exercise: a systematic review and meta-analysis
    Moya-Gallardo, Eduardo
    Fajardo-Gutierrez, Jeniffer
    Acevedo, Karol
    Verdugo-Paiva, Francisca
    Bravo-Jeria, Rocio
    Ortiz-Munoz, Luis
    Contreras-Briceno, Felipe
    Espinosa-Ramirez, Maximiliano
    BMJ OPEN RESPIRATORY RESEARCH, 2024, 11 (02)
  • [45] Effect of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler combined with nasal high-flow nasal cannula on elderly patients with COPD and respiratory failure
    Hu, Feiyan
    Lv, Feijing
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (03) : 353 - 357
  • [46] Combination Therapy in Patients with Acute Respiratory Failure: High-Flow Nasal Cannula and Non-Invasive Mechanical Ventilation
    Segovia, Barbara
    Velasco, Diurbis
    Jaureguizar Oriol, Ana
    Diaz Lobato, Salvador
    ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (03): : 166 - 167
  • [47] Development in PaCO2 over 12 months in patients with COPD with persistent hypercapnic respiratory failure treated with high-flow nasal cannula-post-hoc analysis from a randomised controlled trial
    Storgaard, Line Hust
    Hockey, Hans-Ulrich
    Weinreich, Ulla Moller
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [48] Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study
    Biselli, Paolo J. C.
    Kirkness, Jason P.
    Grote, Ludger
    Fricke, Kathrin
    Schwartz, Alan R.
    Smith, Philip
    Schneider, Hartmut
    JOURNAL OF APPLIED PHYSIOLOGY, 2017, 122 (01) : 82 - 88
  • [49] Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure
    Storgaard, Line Hust
    Hockey, Hans-Ulrich
    Laursen, Birgitte Schantz
    Weinreich, Ulla Moller
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 1195 - 1205
  • [50] A randomised controlled trial of the effect of high concentration oxygen on myocardial ischaemia during exercise
    Ranchord, Anil M.
    Perrin, Kyle
    Weatherall, Mark
    Beasley, Richard
    Simmonds, Mark
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 160 (03) : 201 - 205